Background Despite improvements in treatment and oral pre-exposure prophylaxis (PrEP)
access, 1.3 million people acquired HIV in 2022. Six-monthly lenacapavir PrEP could benefit …

Background We aimed to evaluate the cost-effectiveness of an artificial intelligence-(AI)
based diabetic retinopathy (DR) screening system in the primary care setting for both non …

Introduction The efficacy of pre-exposure prophylaxis (PrEP) is highly dependent on
adherence, and adherence behavior is influenced by motivation. The aim of this study was …

Men who have sex with men (MSM) is a high-risk population for HIV and sexually
transmitted infections (STIs). Pre-exposure prophylaxis (PrEP) is effective in HIV prevention …

Oral and long-acting injectable HIV pre-exposure prophylaxis (PrEP) is highly effective at
preventing HIV infection among men who have sex with men (MSM) who are adherent to …

Introduction Knowledge, attitudes, and perceptions (KAPs) regarding HIV/AIDS is one of the
cornerstones in the fight against the disease. Mortality and morbidity among HIV-infected …

Long-acting injectable PrEP, particularly cabotegravir (CAB-LA), has the potential to
enhance HIV prevention in Asia, and was the topic of a roundtable held in Singapore in …

Oral HIV pre-exposure prophylaxis (PrEP) effectively prevents infection when taken during
periods of risk, however, its population-level effectiveness is hindered by incomplete uptake …

I aim to highlight a crucial, yet often overlooked, aspect of HIV transmission dynamics: the
heightened vulnerability of older Chinese men who have sex with men to HIV acquisition, 2 …

BACKGROUND: China has invested substantial resources in screening and intervening with
people at high risk of stroke in the past decade. Surprisingly, the weighted prevalence of …